Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. Bryan Deneuville from Mont-Saint-Guibert, company number BE1022746323, closed financial year 2025 with a result of € 8,172 after tax. For that financial year Dr. Bryan Deneuville recorded a gross margin of € 14,403 and equity of € 11,172. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 24, 2026.
€ 11,172
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 8,172
Profit after tax over the fiscal year.
€ 11,896
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 8,172.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 23,642
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 22,120
Supplier invoices still open on the last day of the fiscal year.
€ 2,762
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Dr. Bryan Deneuville?
What happened at Dr. Bryan Deneuville in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 8,172. Source: NBB ↗
- New establishment in Mont-Saint-Guibert. KBO
- Bryan Deneuville became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 2,762 in corporate taxes since 2025.
A new publication or filing at Dr. Bryan Deneuville? We notify you, reason included.
Follow Dr. Bryan DeneuvilleDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Bryan Deneuville is Bryan Deneuville.
Directors
According to the 2025 annual accounts
Bryan Deneuville
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Rue Saint-Jean 19B box 1
1435 Mont-Saint-Guibert
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1022.746.323
- VAT number
- BE 1022.746.323
- Registered office
- Rue Saint-Jean 19B bus 1, 1435 Mont-Saint-Guibert
- Names & denominations
- Dr. Bryan Deneuville
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 April 2025
- Peppol
- Active · Active since 6 Feb 2026